Market Cap
$124.03 B
-$2.29 B-1.81%
28 min ago
Summary
- As of February 6, 2025, VRTX market capitalization is $124.03 billion, with a fall of -$2.29 billion (-1.81%) during the most recent trading day.
- Over the past year, VRTX market cap has increased by +$16.79 billion (+15.66%).
- VRTX market cap is now -7.38% below its all-time high of $133.92 billion.
Performance
VRTX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
VRTX Market Cap Trends
PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
---|---|---|---|---|
todaytoday | -1.8% | -1.8% | -0.1% | -1.9% |
1 m1 month | +19.4% | +19.4% | - | +20.1% |
3 m3 months | -2.6% | -2.6% | - | - |
6 m6 months | +1.6% | +1.8% | - | +1.7% |
ytdytd | +21.6% | +21.6% | - | +22.4% |
1 y1 year | +15.7% | +15.7% | -0.1% | - |
5 y5 years | +100.1% | +101.4% | -0.7% | +102.3% |
VRTX Market Cap Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -1.8% | $104 B | +19.4% | |
3 m | 3-month | $134 B | -7.4% | $101 B | +22.3% |
6 m | 6-month | $134 B | -7.4% | $101 B | +22.3% |
1 y | 1-year | $134 B | -7.4% | $101 B | +22.9% |
3 y | 3-year | $134 B | -7.4% | $58 B | +112.2% |
5 y | 5-year | $134 B | -7.4% | $45 B | +173.5% |
alltime | all time | $134 B | -7.4% | $82 M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Market Cap History
Date | Value |
---|---|
2025 | $124.03 B(+21.6%) |
2024 | $101.98 B(-3.0%) |
2023 | $105.17 B(+41.7%) |
2022 | $74.22 B(+32.8%) |
2021 | $55.88 B(-9.0%) |
2020 | $61.42 B(+8.3%) |
2019 | $56.71 B(+34.1%) |
2018 | $42.28 B(+11.4%) |
2017 | $37.95 B(+107.5%) |
2016 | $18.29 B(-41.0%) |
2015 | $30.99 B(+7.9%) |
2014 | $28.72 B(+65.3%) |
2013 | $17.37 B(+90.8%) |
2012 | $9.10 B(+31.0%) |
2011 | $6.95 B(-2.5%) |
2010 | $7.13 B(-16.8%) |
2009 | $8.57 B(+87.4%) |
Date | Value |
---|---|
2008 | $4.57 B(+48.1%) |
2007 | $3.09 B(-34.6%) |
2006 | $4.72 B(+57.7%) |
2005 | $2.99 B(+250.6%) |
2004 | $853.68 M(+5.7%) |
2003 | $807.56 M(-33.3%) |
2002 | $1.21 B(-34.4%) |
2001 | $1.85 B(-56.7%) |
2000 | $4.26 B(+374.1%) |
1999 | $898.98 M(+19.2%) |
1998 | $754.43 M(-9.3%) |
1997 | $832.13 M(-2.0%) |
1996 | $849.15 M(+85.2%) |
1995 | $458.42 M(+77.8%) |
1994 | $257.83 M(+14.5%) |
1993 | $225.22 M(+89.7%) |
1992 | $118.70 M(-32.0%) |
1991 | $174.61 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
- What is VRTX market capitalization year-to-date change?
- What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
What is Vertex Pharmaceuticals Incorporated market capitalization?
The current market cap of VRTX is $124.03 B
What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high market capitalization is $133.92 B
What is VRTX market capitalization year-to-date change?
Vertex Pharmaceuticals Incorporated market capitalization has changed by +$22.05 B (+21.62%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, VRTX market capitalization has changed by +$16.79 B (+15.66%)